Salt Formulation
Salt Formulation - Related Videos
04:08
Determining the pH of Salt Solutions
0 Views •
2020
The pH of a salt solution is determined by its component anions and cations. Salts that contain pH-neutral anions and the hydronium ion-producing cations form a solution with a pH less than 7. For example, in ammonium nitrate (NH4NO3) solution, NO3− ions do not react with water whereas NH4+ ions produce the hydronium ions resulting in the acidic solution. In contrast, salts that contain pH-neutral cations and the hydroxide ion-producing anions form a solution with a pH greater than 7. For...
02:02
Responses to Salt Stress
0 Views •
2020
Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients. Plant cell cytoplasm has a high solute concentration, which causes water to flow from the soil into the plant due to osmosis. However, excess salt in the surrounding soil increases the soil solute concentration, reducing the plant’s ability to take up water. High levels of...
08:55
Formulations for Freeze-drying of Bacteria and Their Influence on Cell Survival
0 Views •
Cited by 22 •
2013
Freeze-drying is often an easy and convenient way to obtain dry products of viable bacterial cells. An issue of the process is cell survival. We detail here a procedure to investigate how cell survival during freeze-drying is influenced by the properties of the formulation used.
01:24
Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila
0 Views •
2025
Take a transgenic Drosophila.The brain of the Drosophila expresses the human amyloid peptide protein or APP and a cleaving enzyme.The enzyme cleaves APP, enabling the formation of beta-amyloid plaque, which leads toAlzheimer's disease or AD pathology in Drosophila.Feed the Drosophila AD model a diet containing a synbiotic formulation.The formulation contains a combination of three bioactive probiotic bacteria and a prebiotic.Inside the fly's gut, the prebiotic supports the growth and survival...
11:16
Hydrophobic Salt-modified Nafion for Enzyme Immobilization and Stabilization
0 Views •
Cited by 23 •
2012
This article will describe the procedure for synthesizing a hydrophobically modified Nafion enzyme immobilization membrane and how to immobilize proteins and/or enzymes within the membrane and test their specific activity.
FAQs
The counterion can change the resulting crystal structure, which in turn affects aqueous solubility, dissolution rate, chemical stability, and handling properties. These changes determine how readily a formulation can be manufactured and how consistently the drug becomes available for oral absorption. Selection therefore requires balancing several properties rather than optimizing a single measurement.
Although they contain the same active moiety, their altered solid-state characteristics can produce different solubility, dissolution, and stability profiles. One form may support faster dissolution, while another may offer better chemical stability or easier handling. Comparative testing identifies whether those differences improve the overall pharmaceutical and clinical performance.
It can influence the sequence linking dosage-form performance, dissolution, and absorption, making the selected form relevant to bioavailability. The goal is not simply to increase solubility, because stability, manufacturing consistency, shelf life, and tolerability also matter. A suitable form provides a reliable balance across these linked development requirements.
Scientists evaluate alternatives against properties relevant to use in a medicine, including aqueous solubility, dissolution rate, chemical stability, handling, and dosage-form performance. They then consider implications for bioavailability, tolerability, manufacturing consistency, and shelf life. This comparative approach helps select the form with the most dependable overall balance.
It is useful when an ionizable drug needs improved pharmaceutical suitability without changing its active moiety. Developers may assess salt alternatives to support oral absorption, consistent manufacturing, dosage-form performance, or longer shelf life. The preferred option depends on how well its physical and chemical properties meet the intended clinical and practical requirements.
It may affect how consistently the dosage form performs, how readily the drug dissolves, and how reliably the product supports oral absorption. Its chemical stability can also influence shelf life, while handling properties affect practical manufacturing. These outcomes connect salt selection with both product quality and patient use.